drugset / Trial / NCT00593255

Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes

NCT00593255

Phase 4 Completed 220 enrolled Novo Nordisk A/S
RandomizedParallel-groupOpen-labelTreatment

Summary

This trial is conducted in Asia. The aim of this trial is to compare the efficacy of postprandial plasma glucose of two treatment regimens in Chinese subjects.

Timeline

Start
2004-07
Primary completion
2005-04
Completion
2005-04

Publications

  • Results Gao Y, Pan C, Zou D, Xu Z, Liu X, Guo X. Superior prandial glucose control with Insulin Aspart compared to Regular Human Insulin in Basal Bolus Therapy with NPH in Patients with Inadequately Controlled T1DM or T2DM. ADA 2006 2006; 55 (Suppl. 1): A464 (2005-PO)

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin aspart Protein / enzyme biologic
Subject soluble human insulin Unknown
Background insulin NPH Protein / enzyme biologic